Cytomegalovirus retinitis developed after rituximab and bendamustine therapy in B cell lymphoma

Tadashi Oyama

Presentation information

Oral Session

Oral Session 3-13D Viral Infection

Sun. Oct 14, 2018 3:00 PM - 4:00 PM No.13 (Osaka International Convention Center, 11F 1101-2)

Chair: Shingo Yano (Division of Oncology and Hematology, Jikei University School of Medicine, Japan)

[OS3-13D-3] Cytomegalovirus retinitis developed after rituximab and bendamustine therapy in B cell lymphoma

Tadashi Oyama¹, Kazuhiko Yamamoto¹, Yutaro Shiraishi¹, Daigo Niiya¹, Masako Itami², Noriko Sakaguchi², Chihiro Kamoi¹, Yuichi Sumii¹, Yoshikazu Yamamoto¹, Kenji Imajo¹ (1.Dept. of Hematology/Oncology, Okayama City Hospital, Okayama, Japan, 2.Dept. of Ophthalmology, Okayama City Hospital, Okayama, Japan)

Abstract password authentication.
Password is written on a program and abstract book.